Quick Answer
RenovoRx, Inc. reported Gross Profit of $796.0 thousand for fiscal year 2025.
RenovoRx, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $796.0K | +1751.2% |
| 2024 | $43.0K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $213.0K | — | -21.1% |
| June 30, 2025 | $270.0K | — | +162.1% |
| March 31, 2025 | $103.0K | — | — |
- RenovoRx, Inc. showed an increase of +1751.2% in Gross Profit compared to the prior fiscal year.
- Over the 2024–2025 period, RenovoRx, Inc.’s gross profit has grown by 1751.2% (from $43.0 thousand to $796.0 thousand).
- The most recent figure is from RenovoRx, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: